NeuroPace Inc — Director's Dealing 2022

Nov 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-10-31

Reporting Person: Kuhn Rebecca (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-31	Common Stock	M	692	$0.026	Acquired	58968	Direct
2022-10-31	Common Stock	M	254	$0.026	Acquired	59222	Direct
2022-10-31	Common Stock	M	482	$0.026	Acquired	59704	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-31	Stock Option (Rt to Buy)	$0.026	M	692	Disposed	2022-11-12	Common Stock (692)	Direct
2022-10-31	Stock Option (Rt to Buy)	$0.026	M	254	Disposed	2024-02-10	Common Stock (254)	Direct
2022-10-31	Stock Option (Rt to Buy)	$0.026	M	482	Disposed	2025-02-09	Common Stock (482)	Direct

Footnotes

F1: The share underlying the option are fully vested.